SUBSCRIBE
SUBSCRIBE
News   Business

Myriad Genetics, Inc. to Report Fiscal 2011 First Quarter Financial Results on November 2

October 13, 2010 | 
1 min read
SALT LAKE CITY, Oct. 12, 2010 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today announced that it will release its fiscal 2011 first quarter financial results at the close of market on Tuesday, November 2, 2010.
Earnings
MORE ON THIS TOPIC
3D illustration of many pawns attracted by a red one. Concept of aura of attraction and charismatic person.3D rendering on black background.
Rare diseases
Dyne Primed for Suitors Amid Novartis’ $12B Avidity Acquisition
October 27, 2025
 · 
2 min read
 · 
Tristan Manalac
Marburg, Germany - July 6, 2013: Marburg Office of Swiss multinational company Novartis AG
M&A
Novartis To ‘Bolster’ Neuromuscular Pipeline With $12B Avidity Acquisition
October 26, 2025
 · 
2 min read
 · 
Heather McKenzie
Pictured: Eli Lilly's headquarters in Indianapolis
Deals
Lilly Dives Deeper Into Gene Therapy With up to $262M Adverum Buy
October 24, 2025
 · 
2 min read
 · 
Heather McKenzie
Accumulated problems, contradictions. Dead end, we need to go back. You cannot continue further. Complete impossibility to continue. Rejection of an idea. Hard sanctions. Fatal error.
CAR-T
Regeneron Cans 2seventy-Acquired CAR T Candidate for Lymphoma in ‘Strategic’ Move
October 24, 2025
 · 
2 min read
 · 
Tristan Manalac